Morgan Stanley Maintains Overweight on Merck & Co, Lowers Price Target to $177
Morgan Stanley Maintains Overweight on Merck & Co, Lowers Price Target to $177
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed